Akura Hiroshi, Nakano Takafumi, Hayashi Toshinobu, Takahashi Masashi, Egawa Takashi
Muscat Pharmacy Co., Ltd.
Department of Pharmaceutical and Health Care Management, Faculty of Pharmaceutical Sciences, Fukuoka University.
Yakugaku Zasshi. 2021;141(2):263-272. doi: 10.1248/yakushi.20-00187.
As one of the strategies for the early detection and treatment of osteoporosis, we have recommended visiting a hospital, based on the Fracture Risk Assessment Tool (FRAX) and evaluation questionnaire for osteoporotic fracture risk. In this study, we evaluated the impact of intervention by community pharmacists by integrating our data for the FRAX and questionnaire. The measurement of FRAX and the questionnaire survey were conducted through participation in health seminars organized by a community general support center from June 2018 to December 2019. Participants with a FRAX score more than 15% and at least one item in the questionnaire were considered to have "suspected osteoporosis" were recommended medical consultation. The medical treatment status for the participants considered to have "suspected osteoporosis" aged 40-90 years were analyzed. Of the 84 participants, 54 had a FRAX score more than 15%, and 44 participants fulfilled at least one item in the questionnaire. Medical consultation was recommended to 26 of these 44 participants, excluding 18 under treatment. Of the 25 participants, six (excluding one who disagreed) received consultation, and medical treatment was started for four of them (66.7%). However, consultation with the attending physician was recommended to five of the 18 participants who were initially on treatment but discontinued it at the time of the survey. Consequently, two participants resumed their osteoporosis treatment. Our data suggest advantages of community pharmacists' intervention using FRAX and a questionnaire for osteoporotic fracture risk measurement for early detection and medical treatment.
作为骨质疏松症早期检测和治疗的策略之一,我们建议根据骨折风险评估工具(FRAX)和骨质疏松性骨折风险评估问卷前往医院就诊。在本研究中,我们通过整合FRAX数据和问卷来评估社区药剂师干预的影响。FRAX测量和问卷调查是通过参与社区综合支持中心于2018年6月至2019年12月组织的健康研讨会进行的。FRAX评分超过15%且问卷中至少有一项符合的参与者被认为“疑似骨质疏松症”,建议其进行医学咨询。对40至90岁被认为“疑似骨质疏松症”的参与者的医疗状况进行了分析。在84名参与者中,54人的FRAX评分超过15%,44名参与者至少符合问卷中的一项。在这44名参与者中,除18名正在接受治疗的参与者外,建议26人进行医学咨询。在这25名参与者中,6人(不包括1名不同意的参与者)接受了咨询,其中4人开始接受治疗(66.7%)。然而,对于18名最初接受治疗但在调查时停止治疗的参与者,建议其中5人咨询主治医生。结果,两名参与者恢复了骨质疏松症治疗。我们的数据表明,社区药剂师使用FRAX和骨质疏松性骨折风险测量问卷进行干预,对于早期检测和治疗具有优势。